Personalized Alzheimer's Disease Prevention and Treatment System

A next-generation system for predicting, preventing, and treating Alzheimer's disease, leveraging machine learning, wearable devices, virtual reality, and blockchain technology to provide personalized treatment plans and slow disease progression.

The original patent disclosed methods for treating mild cognitive impairment and Alzheimer's disease using aluminum salts. However, these methods have limitations, including the need for frequent MMSE assessments and the lack of personalized treatment approaches. The new inventive concept addresses these limitations by introducing a comprehensive system that integrates advanced technologies to provide early detection, prevention, and personalized treatment of Alzheimer's disease.

The system comprises a machine learning algorithm trained on a dataset of AD patient profiles and biomarkers, which predicts AD progression risk based on patient-specific data and recommends personalized treatment plans. A wearable device monitors AD biomarkers in real-time, transmitting data to a cloud-based analytics platform for analysis and alert generation. A virtual reality-based cognitive training platform provides immersive, gamified exercises to improve cognitive function and slow AD progression. A decentralized, blockchain-based AD patient registry enables secure, decentralized data sharing and collaboration among researchers and clinicians. The system integrates these components to provide a holistic approach to AD prevention and treatment.

The new inventive concept introduces a paradigm shift in Alzheimer's disease prevention and treatment by leveraging advanced technologies to provide personalized, data-driven approaches. The machine learning algorithm, wearable device, virtual reality platform, and blockchain-based registry are novel and non-obvious components that differentiate the new inventive concept from the original patent.

Alternative embodiments of the system could include the use of other AI algorithms, different wearable device designs, or variations of the virtual reality platform. Additionally, the system could be adapted for use in other diseases or conditions, such as Parkinson's disease or traumatic brain injury.

The personalized Alzheimer's disease prevention and treatment system has significant commercial potential in the healthcare and pharmaceutical industries. The system could be marketed as a comprehensive solution for AD prevention and treatment, with potential applications in clinical settings, research institutions, and patient care.